JP2024534838A5 - - Google Patents
Info
- Publication number
- JP2024534838A5 JP2024534838A5 JP2024512984A JP2024512984A JP2024534838A5 JP 2024534838 A5 JP2024534838 A5 JP 2024534838A5 JP 2024512984 A JP2024512984 A JP 2024512984A JP 2024512984 A JP2024512984 A JP 2024512984A JP 2024534838 A5 JP2024534838 A5 JP 2024534838A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163238429P | 2021-08-30 | 2021-08-30 | |
| US63/238,429 | 2021-08-30 | ||
| PCT/US2022/075581 WO2023034740A1 (en) | 2021-08-30 | 2022-08-29 | Nkp46-binding polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534838A JP2024534838A (ja) | 2024-09-26 |
| JP2024534838A5 true JP2024534838A5 (cg-RX-API-DMAC7.html) | 2025-08-12 |
Family
ID=84047735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512984A Pending JP2024534838A (ja) | 2021-08-30 | 2022-08-29 | ＮＫｐ４６結合ポリペプチド及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250136681A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4395895A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534838A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117940454A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228815A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202319397A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023034740A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024206329A1 (en) | 2023-03-27 | 2024-10-03 | Modernatx, Inc. | Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof |
| CN120025440A (zh) * | 2023-11-21 | 2025-05-23 | 南京融捷康生物科技有限公司 | 一种抗Nkp46的单域抗体及其用途 |
| WO2025137555A1 (en) * | 2023-12-20 | 2025-06-26 | Omniab, Inc. | Polypeptides that bind to nkp46 |
| TW202602921A (zh) * | 2024-02-09 | 2026-01-16 | 大陸商上海岸邁生物科技有限公司 | 多功能ｎｋ細胞接合器 |
| CN120574323A (zh) * | 2024-02-29 | 2025-09-02 | 安升（上海）医药科技有限公司 | 一种抗NKp46的单域抗体及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016284871B2 (en) * | 2015-06-23 | 2022-09-29 | Innate Pharma | Multispecific NK engager proteins |
| EP3397645B1 (en) * | 2015-12-28 | 2026-03-25 | Innate Pharma | Variable regions for nkp46 binding proteins |
| KR20210005872A (ko) * | 2018-03-28 | 2021-01-15 | 오리오니스 바이오사이언시즈 인코포레이티드 | 이작용성 단백질 및 이의 작제물 |
| SG11202106700WA (en) * | 2019-01-07 | 2021-07-29 | Inhibrx Inc | Polypeptides comprising modified il-2 polypeptides and uses thereof |
-
2022
- 2022-08-29 JP JP2024512984A patent/JP2024534838A/ja active Pending
- 2022-08-29 US US18/685,665 patent/US20250136681A1/en active Pending
- 2022-08-29 WO PCT/US2022/075581 patent/WO2023034740A1/en not_active Ceased
- 2022-08-29 EP EP22798405.1A patent/EP4395895A1/en active Pending
- 2022-08-29 TW TW111132424A patent/TW202319397A/zh unknown
- 2022-08-29 CN CN202280058826.6A patent/CN117940454A/zh active Pending
- 2022-08-29 CA CA3228815A patent/CA3228815A1/en active Pending